Overview
Emily Fruchterman is an associate in Paul Hastings’ Life Sciences Regulatory practice and is based in the Washington, D.C. office. Emily advises pharmaceutical, biotechnology, medical device and other life sciences companies on a broad range of regulatory, compliance and transactional matters arising under the Federal Food, Drug and Cosmetic Act, the Public Health Service Act and related regulatory frameworks.
Emily provides strategic regulatory counsel throughout the product life cycle, including product development, manufacturing, advertising and promotion, and post-market compliance. She also supports strategic transactions involving FDA-regulated products and advises companies on government investigations, internal investigations and other enforcement actions.
Prior to joining Paul Hastings, Emily was a life sciences regulatory and compliance associate at another large U.S. law firm. Emily previously clerked in the U.S. District Court for the Western District of Virginia.
Education
- Georgetown University Law Center, J.D. (order of the coif), 2022
- Johns Hopkins Bloomberg School of Public Health, M.P.H., 2020
- The College of William and Mary, B.S. (magna cum laude), 2015
Representations
- Advised clients on advertising, promotional and labeling matters, including related to scientific exchange, off-label promotion, and false and misleading language and imagery.
- Counseled clients on responding to OPDP untitled letters.
- Represented global medical device manufacturer in parallel FCA and FDCA investigations.
- Assisted medical device companies with internal investigations related to Good Manufacturing Practices, off-label promotion and other compliance concerns.
- Advised pharmaceutical, biotechnology, medical device and food companies in connection with corporate transactions, including mergers and acquisitions, as well as IPOs and follow-on offerings.
Matters may have been completed before joining Paul Hastings.